Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

WST - WEST PHARMACEUTICAL SERVICES INC


Close
309.35
0   0%

Share volume: 0
Last Updated: Tue 24 Dec 2024 06:00:30 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.51%

PREVIOUS CLOSE
CHG
CHG%

$309.35
22.92
0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30
Fiscal Quarter Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024
Report Date 2022-10-27 2023-02-21 2023-04-27 2023-07-27 2023-10-26 2024-02-20 2024-04-25 2024-07-25
Total revenue 686.900 M 708.700 M 716.600 M 753.800 M 747.400 M 732.000 M 695.400 M 702.100 M
Cost of revenue 418.900 M 446.600 M 445.300 M 462.400 M 459.100 M 453.800 M 465.200 M 472.100 M
Gross profit 268.000 M 262.100 M 271.300 M 291.400 M 288.300 M 278.200 M 230.200 M 230.000 M
    -2.20% 3.51% 7.41% -1.06% -3.50% -17.25% -0.09%  
Operating expenses 79.900 M 101.600 M 103.100 M 104.900 M 105.400 M 108.400 M 104.300 M 100.500 M
Selling general and admin 66.300 M 85.700 M 86.000 M 88.400 M 89.000 M 90.000 M 86.700 M 83.000 M
Research and development 13.600 M 15.900 M 17.100 M 16.500 M 16.400 M 18.400 M 17.600 M 17.500 M
Total expenses 498.800 M 548.200 M 548.400 M 567.300 M 564.500 M 562.200 M 569.500 M 572.600 M
    9.90% 0.04% 3.45% -0.49% -0.41% 1.30% 0.54%  
Operating income 188.100 M 160.500 M 168.200 M 186.500 M 182.900 M 169.800 M 125.900 M 129.500 M
Ebit 192.900 M 163.700 M 173.900 M 191.500 M 186.600 M 173.100 M 130.200 M 134.000 M
Pretax income 141.000 M 131.900 M 163.600 M 189.900 M 190.700 M 171.500 M 131.700 M 133.200 M
    -6.45% 24.03% 16.08% 0.42% -10.07% -23.21% 1.14%  
Income tax 20.400 M 28.900 M 23.600 M 34.800 M 29.400 M 34.500 M 16.400 M 21.900 M
Net income basic 120.600 M 103.000 M 140.000 M 155.100 M 161.300 M 137.000 M 115.300 M 111.300 M
    -14.59% 35.92% 10.79% 4.00% -15.07% -15.84% -3.47%  
Net income 120.600 M 103.000 M 140.000 M 155.100 M 161.300 M 137.000 M 115.300 M 111.300 M
    -14.59% 35.92% 10.79% 4.00% -15.07% -15.84% -3.47%